跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 149 条关于
“PARASOL”
全部
149
临床试验
54
药物
66
机构
5
资讯
24
去年
PARASOL Workshop Suggests Broader Proteinuria Endpoints for FSGS Drug Approval
去年
PARASOL Initiative Identifies Proteinuria as Surrogate Endpoint in FSGS Trials
11个月前
Dimerix's DMX-200 Advances in Phase 3 FSGS Trial with Strong Safety Profile and FDA-Aligned Endpoint Data
去年
Nephrology Month in Review: December 2024
去年
Dimerix Advances Kidney Disease Trial with Key Endpoint Validation
去年
Travere Therapeutics Plans sNDA Submission for FILSPARI to Treat Rare Kidney Disease FSGS
去年
FDA Confirms Proteinuria as Primary Endpoint for Dimerix's DMX-200 Phase 3 FSGS Trial
9个月前
Dimerix Completes Recruitment for Phase 3 Trial of DMX-200 in Rare Kidney Disease FSGS
10个月前
Sparsentan Shows Superior Proteinuria Reduction in Pediatric FSGS Patients Compared to Standard Care
10个月前
Dry AMD Market Set for Significant Growth Through 2034 as Novel Therapies Advance in Clinical Development
第 1 页,共 3 页
上一页
下一页